Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Isaac E Silverman"'
Autor:
Carmel Armon, David B. Matchar, Lois Copperman, Andres M. Kanner, Isaac E. Silverman, Olivier T. Rutschmann, Robert S. Goldman, Douglas C McCrory, Douglas S. Goodin, Michael A. Sloan, Yuen T. So, Thomas Marrie, David Hammond, David S. Lefkowitz, Chung Y. Hsu, Dennis Bourdette, Cindy Phair, John R. Richert, Patricia K. Coyle, Elliot M. Frohman, Deborah M. Miller, Frank DeStafano
Publikováno v:
Neurology. 59:1837-1843
Objective: To review the risk of MS exacerbations after infectious episodes potentially preventable by vaccination, and the risks and benefits of immunizing patients with MS. Methods: The authors searched MEDLINE (1966 to January 2001; U.S. National
Autor:
Steven Galetta, Isaac E. Silverman
Publikováno v:
Neuro-Ophthalmology. 15:127-134
Hemiachromatopsia, the acquired impairment of hemifield color vision, usually results from an infarction to the contralateral occipitotemporal cortex. Generally, patients with hemiachromatopsia hav...
Autor:
Craig I Coleman, Jennifer Colby, Isaac E Silverman, William L. Baker, Vanita Tongbram, C Michael White, Ripple Talati, Jeffrey Kluger
Publikováno v:
Annals of internal medicine. 154(4)
Acute ischemic strokes are associated with poor outcomes and high health care burden. Evidence exists evaluating the use of neurothrombectomy devices in patients receiving currently recommended treatments that may have limited efficacy.To describe th
Publikováno v:
Connecticut medicine. 74(2)
Autor:
Robert J. Wityk, Gretchen L. Dike, Isaac E. Silverman, Gene Sung, Brian Litt, David M. Berman
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 9:196-198
We report a 37-year-old woman with Marfan syndrome (MFS) who presented with acute myelopathy secondary to a subdural spinal hematoma. The patient died of a subarachnoid hemorrhage 4 days later. Autopsy showed a markedly ectatic vertebrobasilar system
Publikováno v:
JAMA Neurology. 72:1073
Publikováno v:
Cerebrovascular diseases (Basel, Switzerland). 23(4)
Background and Purpose: Though the proportion of elderly stroke patients is increasing, patients >80 years are often excluded from clinical stroke trials. We reviewed the management of older patients presenting with acute ischemic stroke (AIS) and as
Publikováno v:
Connecticut medicine. 69(10)
Acute stroke therapy with intravenous (IV) tissue plasminogen activator (t-PA) is vastly underutilized. Increasingly, patients are being started on IV t-PA and being transferred to regional Stroke Center programs, where additional therapies can be of
Autor:
Eric Shore, Sri G. Kakarala, Roger P. Clark, Isaac E Silverman, Patrick J. Troy, Jocelyn Burns
Publikováno v:
Neurocritical care. 2(1)
Introduction: Diabetic ketoacidosis (DKA) continues to be a medical emergency, in part because of a rare and devastating complication associated with its treatment, cerebral edema. In children, cerebral edema is the principal cause of mortality, but
Autor:
Gene Sung, Thomas Grobelny, Gary M. Nesbit, Ronald F. Budzik, Sidney Starkman, Jeffrey L. Saver, Marilyn M. Rymer, Wade S. Smith, Chelsea S. Kidwell, Y. Pierre Gobin, Randall T. Higashida, Helmi L. Lutsep, Michael P. Marks, Isaac E. Silverman
Publikováno v:
Stroke. 36(7)
Background and Purpose— The only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke is tissue plasminogen activator (tPA) given intravenously within 3 hours of symptom onset. An alternative strategy for opening intracra